Biomaterials comprising implantable and dermal drug delivery targeting brain in management of alzheimer's disease: a review
NS Kiran, G Vaishnavi, S Singh, C Yashaswini… - Regenerative …, 2024 - Springer
Purpose Alzheimer's disease (AD) is regarded as the most common neurological condition
in terms of cognition. The disease progresses gradually, begin with a slight memory loss and …
in terms of cognition. The disease progresses gradually, begin with a slight memory loss and …
SARS-CoV-2 invasion and pathological links to prion disease
WJ Lukiw, VR Jaber, AI Pogue, Y Zhao - Biomolecules, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …
SARS-CoV-2, long COVID, prion disease and neurodegeneration
Y Zhao, VR Jaber, WJ Lukiw - Frontiers in Neuroscience, 2022 - frontiersin.org
On the last day of the year 2019 a novel Betacoronavirus (2019-nCov), now known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …
Is dementia associated with COVID-19 mortality? A multicenter retrospective cohort study conducted in 50 hospitals in Germany
K Kostev, N Gessler, P Wohlmuth… - Journal of …, 2023 - content.iospress.com
Background: Dementia has been identified as a major predictor of mortality associated with
COVID-19. Objective: The objective of this study was to investigate the association between …
COVID-19. Objective: The objective of this study was to investigate the association between …
Risk of adverse events and delirium after COVID-19 vaccination in patients living with dementia
Objectives The aim of this study was to compare incidences of adverse events of special
interest (AESI) and delirium in 3 cohorts: after COVID-19 vaccination, prepandemic, and …
interest (AESI) and delirium in 3 cohorts: after COVID-19 vaccination, prepandemic, and …
microRNA, the innate-immune system and SARS-CoV-2
JM Hill, WJ Lukiw - Frontiers in Cellular and Infection Microbiology, 2022 - frontiersin.org
The single-stranded viral RNA (ssvRNA) known as the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that causes COVID-19 can be effectively inactivated by a …
coronavirus 2 (SARS-CoV-2) that causes COVID-19 can be effectively inactivated by a …
Adolescents' knowledge regarding Alzheimer's disease is declining: An international study
Y Roitblat, E Faridnia, A Morgan… - Educational …, 2024 - Taylor & Francis
To improve school-based mental health literacy programs, we assessed adolescents'
familiarity with Alzheimer's disease (AD). We investigated the frequency of their contact with …
familiarity with Alzheimer's disease (AD). We investigated the frequency of their contact with …
SARS-CoV-2 neuroinvasion, inflammatory neurodegeneration and Alzheimer's disease
Y Zhao, WJ Lukiw - Frontiers in cellular neuroscience, 2022 - frontiersin.org
COVID-19 is a rapid onset, highly transmissible and lethal viral pneumonia caused by the
novel severe acute respiratory syndrome coronavirus SARS-CoV-2. SARS-CoV2 is currently …
novel severe acute respiratory syndrome coronavirus SARS-CoV-2. SARS-CoV2 is currently …
Do prior neurological comorbidities predict COVID-19 severity and death? A 25-month cross-sectional multicenter study on 7370 patients
Background The prognosis of COVID-19 cases that suffer from particular comorbidities is
worse. The impact of chronic neurological disorders (CNDs) on the outcome of COVID-19 …
worse. The impact of chronic neurological disorders (CNDs) on the outcome of COVID-19 …